Skip to main content
Medicine logoLink to Medicine
. 2022 Nov 11;101(45):e31579. doi: 10.1097/MD.0000000000031579

A fertility-sparing surgery in lymphoepithelioma-like carcinomas of the uterine cervix: A case report

So Hee Kim a, Hyung Joon Yoon a, Nam Kyung Lee b, Kyung Un Choi c, Ki Hyung Kim a, Dong Soo Suh a,*
PMCID: PMC9666136  PMID: 36397341

Introduction:

A poorly differentiated lymphoepithelioma-like carcinoma (LELC) of the cervix is an extremely rare presentation. We herein present an unusual case of LELC of the cervix, which was treated with radical trachelectomy for fertility preservation.

Patient concerns:

A 28-year-old female patient presented with a 1-month-history of post-coital vaginal bleeding, and a 2 cm tumor was found on gynecological sonography and magnetic resonance imaging.

Diagnosis:

The final pathological examination established a conclusive diagnosis of LELC of the cervix. After surgery, the patient was finally diagnosed as The International Federation of Gynecology and Obstetrics (FIGO) stage IB1 with no vaginal wall or parametrium infiltration.

Interventions:

Subsequently, a surgery was scheduled, and intraoperatively, we performed resection twice because of a frozen biopsy result that was resection margin-positive initially. As a result, further resection was performed, which was a 5mm thickness for each. Cisplatin adjuvant chemotherapy was administered 3 weeks after the operation to prevent recurrence.

Outcomes:

The patient has been followed for 1 year postoperatively, with an adjuvant treatment, with no evidence of tumor recurrence or metastasis.

Conclusion:

Based on this case, we highly recommend that operators should consider a deeper resection margin range than that visible on magnetic resonance imaging. More attention is needed to better understand the treatment method for LELC of the cervix. We also plan to closely monitor the patient’s prognosis and fertility, and to conduct additional studies.

Keywords: cervix uteri, fertility preservation, human papillomavirus type 16, squamous cell carcinoma, uterine cervical neoplasms

1. Introduction

Cervical cancer is the third most common malignancy of the gynecologic tract, with an estimated 12,000 new cases diagnosed each year in the United States. In 2019, 58,000 new cases of cervical cancer were reported in Korea, accounting for 2.7% of total cancer incidence. Cervical cancer is classified histologically into numerous subtypes, with squamous cell carcinoma being the most common (65%–80%), followed by adenocarcinoma (15%–25%).[1] Additionally, neuroendocrine tumors, adenosquamous carcinoma, carcinosarcoma, and non-epithelial neoplasms are less common histologies.

According to the World Health Organization’s histological categorization of tumors, lymphoepithelioma-like carcinoma (LELC) is an uncommon subtype that is best categorized as a variant of SCC in the cervix. In all patients with stage 1 cervical cancer, the incidence of LELC is approximately 3.3%.[2] Although LELCs are frequently detected in the nasopharynx, they may also be found in the stomach, thymus, urinary bladder, lungs and salivary glands.[3] Histologically, it is characterized by poorly differentiated tumor cells with abundant cytoplasm and intense chronic inflammatory infiltration.[2]

Various studies on the pathogenesis of LELC in Epstein-Barr virus (EBV) and Human Papillomavirus (HPV) infections have been published. EBV has been suggested as a possible causative factor of LELC, particularly in Asian women, but not in white women.[4] The role of HPV in the pathogenesis of cervical LELC is unknown; the presence of HPV has been studied in only a small number of cases.

This report presents a case of LELC in a relatively young Korean woman who underwent radical trachelectomy for fertility preservation. This patient showed a HPV 16 positivity but absence of EBV.

2. Case presentation

A 28-year-old Korean woman, gravida 0, was referred to Pusan National University’s Department of Obstetrics and Gynecology. She visited a gynecologist of local medical center because of post-coital bleeding that persisted for a month. Her most recent gynecological examination and cervical smear were both normal 1 year ago. Cytology and histology tests performed at a local medical center revealed squamous cell carcinoma. A HPV DNA chip test detected HPV-16. Additional gynecological ultrasonography revealed a tumor in the cervix measuring 2 cm in diameter.

She was admitted to Pusan National University for further evaluation, which included a hematological profile, magnetic resonance imaging (MRI), and positron emission tomography. Her hematological profile was normal, and her serum squamous cell carcinoma antigen level (1.98 ng/mL) was also within normal limits. MRI and positron emission tomography revealed a 1.7 cm tumor in the anterior lip of the cervix (Fig. 1A–D) and a 2.2 cm hemorrhagic cyst in the right ovary, and no distant metastatic lesions or enlarged lymph nodes.

Figure 1.

Figure 1.

MRI of lymphoepithelioma-like carcinomas (LELCs) of the cervix (clock-wise A, B, C, D) (A, B) Sagittal (A) and axial (B) T2-weighted images show a focal mass (arrow) in the anterior lip of the exocervix. (C) Contrast-enhanced axial T1-weighted image shows a hypovascular cervical mass (arrow). (D) Diffusion-weighted image at b = 1000 s/mm2 shows hyperintensity (arrow) in the cervical mass. MRI = magnetic resonance imaging.

We determined that the patient’s radiology stage was FIGO (The International Federation of Gynecology and Obstetrics) IB1, and decided to perform trachelectomy rather than radical hysterectomy to preserve the patient’s fertility. Open radical trachelectomy and bilateral pelvic lymphadenectomy were performed in March 2021. During the operation, we performed resection twice because of a frozen biopsy result that was resection margin-positive initially. Then, we performed endocervical curettage for frozen biopsy. A frozen biopsy showed suspicion of endo-margin positive and loop electrosurgical excision was done for endocervix resection followed by abdominal cerclage.

After surgery, the patient was finally diagnosed as FIGO stage IB1 with no vaginal wall or parametrium infiltration, and pathological examination revealed some tumor parts with extensive lymphocyte infiltration and lesions that resemble lymphoma and the immunostaining was positive for p53, diffuse positive p63, p16, and pan-cytokeratin. These findings are consistent with LELC of cervix. There was no evidence of lymphatic invasion (Fig. 2A) or lymph node metastasis. Additionally, in situ hybridization to EBV encoded early RNA (Fig. 2B) was performed on formalin-fixed paraffin-embedded tissue to investigate the association between EBV and LELC. However, the result was negative.

Figure 2.

Figure 2.

Microscopic findings. (A) [H&E × 200] The tumor shows poorly differentiated epithelioid cells with marked lymphoid cell infiltration. (B) [EBVISH × 200] Negative result of in situ hybridization for Epstein-Barr virus-encoded early RNA on formalin-fixed paraffin embedded tissue.

The patient’s postoperative course was uneventful. Cisplatin adjuvant chemotherapy was administered 3 weeks after the operation to prevent recurrence. The patient was followed for 1 year after 6 cycles of cisplatin 80 mg chemotherapy with no evidence of recurrence and other complications.

3. Discussion

LELC is an uncommon subtype of squamous cell carcinoma. Previous studies on LELC of the cervix between 1997 and 2017 are listed in Table 1. Histologically, it was identified by nests of undifferentiated epithelial cells that grew in a syncytial pattern and were infiltrated by severe lymphocyte infiltrates.[15] LELCs have been included in prior reviews of “inflammatory” cervical neoplasms.[16] This microscopic characteristic can help in differentiating LELC of the cervix.

Table 1.

Reported cases of LELC of cervix in the literature.

Author Country Case no. Age (yr) (or median) EBV HPV FIGO stage Treatment Adjuvant treatment
Tseng et al[5] Taiwan 15 56 (37–72) Negative 16 IB(9) RH, BPLND None
IIA1(2) Radiotherapy
IIB(4)
Takai et al[6] Japan 3 41 Negative Negative IB1 RH, BPLND No report
69 Negative Negative IIA RH, BPLND No report
44 Negative Negative IB1 RH, BPLND No report
Saroha et al[7] India 2 40 Not done Not done IB1 RH, BPLND, PALND No report
43 Not done Not done IB1 RH, BSO, BPLND, PALND No report
Bais et al[2] Netherlands 1 44 Negative 16, 45 IB1 RH, BPLND None
Table 1. Reported cases of LELC of cervix in the literature
Martorell et al[8] Spain 4 74 Negative Negative IB1 RH, BPLND No report
58 Negative Negative IB1 RH, BPLND No report
77 Negative Negative II RH, BPLND No report
67 Negative Negative IB1 RH, BPLND No report
Noel et al[4] Belgium 2 56 Negative 16 IB1 RH, BPLND No report
53 Negative 18 IB1 RH, BPLND No report
Lopez-Rios et al[9] Spain 1 44 Positive Not done IB1 RH, BPLND No report
Saylam et al[10] Belgium 1 72 Not done 18 IB1 RH, BPLND None
Takebayashi et al[11] Japan 1 45 Negative Not done IB3 RH Radiotherapy
Table 1. Reported cases of LELC of cervix in the literature
Kaul et al[12] India 1 42 Not done Not done IB1 RH, BPLND No report
Kim et al[13] Korea 1 57 Negative Negative IB1 RH, BSO, BPLND, PALND, appendectomy Paclitaxel + cisplatin
Ki et al[14] Korea 1 63 Positive 16 IB1 RH, BSO, BPLND, appendectomy None
Yoo et al[15] Korea 1 55 Not done Not done IB1 RH, BSO, BPLND None
Yun et al[15] Korea 1 45 Negative Negative IB1 RH, BPLND None

BPLND = bilateral pelvic lymph node dissection, BSO: Bilateral salpingo-oophorectomy, EBV = Epstein-Barr virus, FIGO stage = 2018 FIGO Staging System for Uterine Cervical Cancer, HPV = human papilloma virus, PALND = para-aortic lymph node dissection, RH = radical hysterectomy.[19]

The pathogenesis of LELC is unclear; however, it is assumed that either EBV or HPV plays an important role as a causative factor.[17] EBV is not directly involved in squamous cell malignant transformation, but may have an effect on the inflammatory component. Tseng et al[5] reported that 73.3% (11/15) of Asian women with LELC of the cervix were positive for EBV antibodies.[15] However, there are no definite findings that EBV acts as the main factor in cervical cancer in Caucasians.[9] It can be assumed that race and ethnicity can influence the role of EBV gene as an oncogenic factor.[5] With regards to HPV, an association with HPV infection has also been postulated. HPV infection has been identified as a causative factor in the pathogenesis of cervical cancer. Despite this assumption, it is difficult to find a specific association between EBV and HPV positivity in Asian cases (Table 1). In this case, in situ hybridization for EBV-encoded early RNAs was performed, and there was no EBV infection, but HPV 16 was positive.

Patients with LELC had an average age of 49.6 years. Fourteen patients (82.4%) were classified as FIGO IBI, while 3 patients (17.6 %) were classified as FIGO IB2. Three patients (17.6 %) had metastatic lymph nodes, thirteen (76.5 %) had non-metastatic lymph nodes, and 1 patient had been unknown.[18] The incidence in Asia is higher than that in Western countries.[8] Our case was a 28 years old woman, which was younger than the mean age.

There have been some cases and original articles on LELC of the cervix. Most prior cases focused on the diagnosis and case itself. There was not much focus on the treatment of LELC. When it comes to treatment, while radiation therapy can be used at any stage of disease, surgery is only recommended for patients with stage I to IIA disease. LELC has a better prognosis than other types of cervical cancer.[2] Van Nagell et al[19] also reported that LELC of the cervix had lower lymph node metastasis and recurrence rate. Radical hysterectomy is a surgical procedure that is commonly used to treat LELC of the uterus. In this case, we performed radical trachelectomy to preserve fertility. This is the first case of LELC treated with radical trachelectomy in Korea.

Before surgery, we determined the resection margin using the MRI results. During the operation, we performed resection twice because of a frozen biopsy result, which was endo-margin positive at first. The second endocervical resection was performed using the loop electrosurgical excision. Further resection was a 5 mm thickness for each. Therefore, we resected the cancerous lesion at 1cm above from its suspected margin according to its MRI. Based on this experience, we highly recommend that the operator should consider the margin range deeper than that seen on MRI. It’s not certain whether it was just this patient’s physical feature or LELC of the cervix itself. Since LELC of the cervix is a rare disease, there are still many issues to be considered. More attention is needed to better understand the treatment method for LELC of the cervix. We also plan to closely monitor the patient’s prognosis and fertility, and to conduct additional studies.

This patient has agreed an informed consent before this case report was written.

Author contributions

Conceptualization: Dong Soo Suh.

Supervision: Ki Hyung Kim, Dong Soo Suh.

Validation: Kyung Un Choi.

Visualization: Nam Kyung Lee.

Writing – original draft: So Hee Kim.

Writing – review & editing: Hyung Joon Yoon.

Abbreviations:

EBV =
Epstein-Barr virus
FIGO =
the international federation of gynecology and obstetrics
HPV =
human papillomavirus
LELC =
differentiated lymphoepithelioma-like carcinoma
MRI =
magnetic resonance imaging

This work was supported by a clinical research grant from Pusan National University Hospital in 2022.

The study protocol was reviewed and approved by the Institutional Review Board of Pusan National University Hospital.

The authors have no conflicts of interest to disclose.

The datasets generated during and/or analyzed during the current study are publicly available.

How to cite this article: Kim SH, Yoon HJ, Lee NK, Choi KU, Kim KH, Suh DS. A fertility-sparing surgery in lymphoepithelioma-like carcinomas of the uterine cervix: A case report. Medicine 2022;101:45(e31579).

Contributor Information

So Hee Kim, Email: ghkim@pusan.ac.kr.

Hyung Joon Yoon, Email: princeps21@naver.com.

Nam Kyung Lee, Email: leenk77@daum.net.

Kyung Un Choi, Email: kuchoi@pusan.ac.kr.

Ki Hyung Kim, Email: ghkim@pusan.ac.kr.

References

  • [1].Winer I, Alvarado-Cabrero I, Hassan O, et al. The prognostic significance of histologic type in early stage cervical cancer—a multi-institutional study. Gynecol Oncol. 2015;137:474–8. [DOI] [PubMed] [Google Scholar]
  • [2].Bais AG, Kooi S, Teune TM, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus, but presence of a multiple human papillomavirus infection. Gynecol Oncol. 2005;97:716–8. [DOI] [PubMed] [Google Scholar]
  • [3].Pinto A, Huang M, Nadji M. Lymphoepithelioma-like carcinoma of the uterine cervix: a pathologic study of eight cases with emphasis on the association with human papillomavirus. Am J Clin Pathol. 2019;151:231–9. [DOI] [PubMed] [Google Scholar]
  • [4].Noel J, Lespagnard L, Fayt I, et al. Evidence of human papilloma virus infection but lack of Epstein-Barr virus in lymphoepithelioma-like carcinoma of uterine cervix: report of two cases and review of the literature. Hum Pathol. 2001;32:135–8. [DOI] [PubMed] [Google Scholar]
  • [5].Tseng CJ, Pao CC, Tseng LH, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: association with Epstein-Barr virus and human papillomavirus. Cancer. 1997;80:91–7. [DOI] [PubMed] [Google Scholar]
  • [6].Takai N, Nakamura S, Goto K, et al. Lymphoepithelioma-like carcinoma of the uterine cervix. Arch Gynecol Obstet. 2009;280:725–7. [DOI] [PubMed] [Google Scholar]
  • [7].Saroha V, Gupta P, Singh M, et al. Lymphoepithelioma-like carcinoma of the cervix. J Obstet Gynaecol. 2010;30:659–61. [DOI] [PubMed] [Google Scholar]
  • [8].Martorell MA, Julian JM, Calabuig C, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: a clinicopathologic study of 4 cases not associated with Epstein-Barr virus, human papillomavirus, or simian virus 40. Arch Pathol Lab Med. 2002;126:1501–5. [DOI] [PubMed] [Google Scholar]
  • [9].López-Ríos F, Miguel PS, Bellas C, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: a case report studied by in situ hybridization and polymerase chain reaction for Epstein-Barr virus. Arch Pathol Lab Med. 2000;124:746–7. [DOI] [PubMed] [Google Scholar]
  • [10].Saylam K, Anaf V, Fayt I, et al. Lymphoepithelioma-like carcinoma of the cervix with prominent eosinophilic infiltrate: an HPV-18 associated case. Acta Obstet Gynecol Scand. 2002;81:564–6. [DOI] [PubMed] [Google Scholar]
  • [11].Takebayashi K, Nishida M, Matsumoto H, et al. A case of lymphoepithelioma-like carcinoma in the uterine cervix. Rare Tumors. 2015;7:5688. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Kaul R, Gupta N, Sharma J, et al. Lymphoepithelioma-like carcinoma of the uterine cervix. J Cancer Res Ther. 2009;5:300–1. [DOI] [PubMed] [Google Scholar]
  • [13].Kim ML, You HJ, Yoon ES, et al. A case of lymphoepithelioma-like carcinoma of the uterine cervix. Korean J Obstet Gynecol. 2007;50:207–11. [Google Scholar]
  • [14].Ki EY, Ro DY, Kim HJ, et al. A case of lymphoepithelioma-like carcinoma of the uterine cervix. Korean J Obstet Gynecol. 2009;52:115–9. [Google Scholar]
  • [15].Yun HS, Lee SK, Yoon G, et al. Lymphoepithelioma-like carcinoma of the uterine cervix. Obstet Gynecol Sci. 2017;60:118–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Mills SE, Austin MB, Randall ME. Lymphoepithelioma-like carcinoma of the uterine cervix. A distinctive, undifferentiated carcinoma with inflammatory stroma. Am J Surg Pathol. 1985;9:883–9. [DOI] [PubMed] [Google Scholar]
  • [17].Kohrenhagen N, Eck M, Höller S, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus and high-risk human papilloma virus infection. Arch Gynecol Obstet. 2008;277:175–8. [DOI] [PubMed] [Google Scholar]
  • [18].Yordanov A, Karamanliev M, Karcheva M, et al. Single-center study of lymphoepithelioma-like carcinoma of uterine cervix over a 10-year period. Medicina (Kaunas). 2019;55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].van Nagell JR, Jr., Donaldson ES, Wood EG, et al. The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer. Cancer. 1978;41:228–34. [DOI] [PubMed] [Google Scholar]

Articles from Medicine are provided here courtesy of Wolters Kluwer Health

RESOURCES